Guo Zong-Ru
Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China.
Yao Xue Xue Bao. 2012 Feb;47(2):144-57.
Pharmacological activity and druggability are two essential factors for drug innovation. The pharmacological activity is definitely indispensable, and the druggability is destined by physico-chemical, biochemical, pharmacokinetic and safety properties of drugs. As secondary metabolites of animals, plants, microbes and marine organisms, natural products play key roles in their physiological homeostasis, self-defense, and propagation. Natural products are a rich source of therapeutic drugs. As compared to synthetic molecules, natural products are unusually featured by structural diversity and complexity more stereogenic centers and fewer nitrogen or halogen atoms. Naturally active substances usually are good lead compounds, but unlikely meet the demands for druggability. Therefore, it is necessary to modify and optimize these structural phenotypes. Structural modification of natural products is intent to (1) realize total synthesis ready for industrialization, (2) protect environment and resources, (3) perform chemical manipulation according to the molecular size and complexity of natural products, (4) acquire novel structures through structure-activity relationship analysis, pharmacophore definition, and scaffold hopping, and (5) eliminate unnecessary chiral centers while retain the bioactive configuration and conformation. The strategy for structural modification is to increase potency and selectivity, improve physico-chemical, biochemical and pharmacokinetic properties, eliminate or reduce side effects, and attain intellectual properties. This review elucidates the essence of natural products-based drug discovery with some successful examples.
药理活性和成药性是药物创新的两个关键因素。药理活性固然不可或缺,而成药性则由药物的物理化学、生化、药代动力学和安全性特性所决定。作为动物、植物、微生物和海洋生物的次生代谢产物,天然产物在其生理稳态、自我防御和繁殖过程中发挥着关键作用。天然产物是治疗药物的丰富来源。与合成分子相比,天然产物具有结构多样性和复杂性的独特特征——更多的立体中心以及更少的氮或卤素原子。天然活性物质通常是良好的先导化合物,但不太可能满足成药性的要求。因此,有必要对这些结构表型进行修饰和优化。天然产物的结构修饰旨在:(1)实现可工业化的全合成;(2)保护环境和资源;(3)根据天然产物的分子大小和复杂性进行化学操作;(4)通过构效关系分析、药效团定义和骨架跃迁获得新结构;(5)消除不必要的手性中心,同时保留生物活性构型和构象。结构修饰的策略是提高效力和选择性,改善物理化学、生化和药代动力学性质,消除或减少副作用,并获得知识产权。本文通过一些成功案例阐明了基于天然产物的药物发现的本质。